153 related articles for article (PubMed ID: 36835637)
1. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator.
Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637
[TBL] [Abstract][Full Text] [Related]
2. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.
Jiang X; Jiang Y; Luo S; Sekar K; Koh CKT; Deivasigamani A; Dong Q; Zhang N; Li S; Hao F; Goh BKP; Ooi LL; Wang Y; Hui KM
Cancer Res Treat; 2021 Oct; 53(4):944-961. PubMed ID: 33421974
[TBL] [Abstract][Full Text] [Related]
3. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
Lv S; Xu W; Zhang Y; Zhang J; Dong X
Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
[TBL] [Abstract][Full Text] [Related]
4. [Expression of NUF2 in breast cancer and its clinical significance].
Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
Hu P; Chen X; Sun J; Bie P; Zhang LD
Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
[TBL] [Abstract][Full Text] [Related]
6. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
7. G-Protein-Coupled Receptor 5 (LGR5) Overexpression Activates β-Catenin Signaling in Breast Cancer Cells via Protein Kinase A.
Chen Z; Xue C
Med Sci Monit Basic Res; 2019 Jan; 25():15-25. PubMed ID: 30662060
[TBL] [Abstract][Full Text] [Related]
8. TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5.
Jin X; Wang D; Lei M; Guo Y; Cui Y; Chen F; Sun W; Chen X
J Transl Med; 2022 May; 20(1):191. PubMed ID: 35509067
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
Ge L; Sun Q; Xia L; Xu X
Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
[TBL] [Abstract][Full Text] [Related]
10. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
[TBL] [Abstract][Full Text] [Related]
11. NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
Lin J; Chen X; Yu H; Min S; Chen Y; Li Z; Xie X
Int J Biol Sci; 2022; 18(9):3621-3635. PubMed ID: 35813477
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Pei J; Wang Y; Li Y
J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
14. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
15. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
16. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
Front Oncol; 2021; 11():656509. PubMed ID: 34178642
[TBL] [Abstract][Full Text] [Related]
17. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.
Li W; Yang X; Shi C; Zhou Z
Cell Transplant; 2020; 29():963689720960174. PubMed ID: 32951449
[TBL] [Abstract][Full Text] [Related]
19.
Xie X; Jiang S; Li X
Front Oncol; 2021; 11():621373. PubMed ID: 33767990
[No Abstract] [Full Text] [Related]
20. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]